Project information
Telomerase activity as a novel prognostic factor in multiple myeloma
- Project Identification
- NC7043
- Project Period
- 1/2002 - 12/2004
- Investor / Pogramme / Project type
-
Ministry of Health of the CR
- R&D of Oncology
- MU Faculty or unit
- Faculty of Medicine
- Keywords
- multiple myeloma;prognostic factors;telomerase
- Cooperating Organization
-
Institute of Biophysics
- Responsible person prof. RNDr. Jiří Fajkus, CSc.
- Responsible person prof. MUDr. Miroslav Penka, CSc.
Telomerase assay in multiple myeloma is new perspective prognostic factor in multiple myeloma The use od hTERT as tumor antigen is promising new treatment modality and could circumvent limitation of current vaccination protocols in multiple myeloma in which low immunogenic antigens and consequently minimal responses are reported.
Publications
Total number of publications: 4
2005
-
Application of the myeloma bank
Year: 2005, type: Conference abstract
-
Imunomagnetická separace buněk z kostní dřeně u pacientů s mnohočetným myelomem stanovení delece 13q14 použitím interfázní fluorescenční in situ hybridizace
Klinická onkologie, year: 2005, volume: 18, edition: 2
-
Stanovení aktivity telomerázy u mnohočetného myelomu
Klinická onkologie, year: 2005, volume: 18, edition: 3
2004
-
Telomerase activity in multiple myeloma patients
Year: 2004, type: R&D Presentation